Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries
Over the past few years, many innovative vaccines became available that offer protection for diseases which have never been prevented before. While there are several factors that could have an impact on access, the use of health technology assessment (HTA) undoubtedly is also one of the contributing...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-07-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2020.1769388 |
| _version_ | 1797677305196183552 |
|---|---|
| author | Suthira Taychakhoonavudh Woralak Chumchujan Raymond Hutubessy Nathorn Chaiyakunapruk |
| author_facet | Suthira Taychakhoonavudh Woralak Chumchujan Raymond Hutubessy Nathorn Chaiyakunapruk |
| author_sort | Suthira Taychakhoonavudh |
| collection | DOAJ |
| description | Over the past few years, many innovative vaccines became available that offer protection for diseases which have never been prevented before. While there are several factors that could have an impact on access, the use of health technology assessment (HTA) undoubtedly is also one of the contributing factors. Objectives: To explore the landscape of vaccine access and the role of HTA in new vaccine adoption in Association of Southeast Asian Nations (ASEAN) countries. Results: A great deal of progress has been made in terms of access to new and innovation vaccine in the region. Variation in access to these vaccines comparing between countries, however, is still observed. The use of HTA in supporting new vaccine adoption is still in an early stage especially in Gavi, the Vaccine Alliance-eligible countries. Conclusions: Improving the use of HTA evidences to support decision making could accelerate the efficient adoption of new vaccine in ASEAN region. |
| first_indexed | 2024-03-11T22:42:46Z |
| format | Article |
| id | doaj.art-d1fd92f9ee3f4a33b2085eb50baab492 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:42:46Z |
| publishDate | 2020-07-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-d1fd92f9ee3f4a33b2085eb50baab4922023-09-22T08:51:49ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2020-07-011671728173710.1080/21645515.2020.17693881769388Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countriesSuthira Taychakhoonavudh0Woralak Chumchujan1Raymond Hutubessy2Nathorn Chaiyakunapruk3Chulalongkorn UniversityChulalongkorn UniversityWorld Health OrganizationCollege of Pharmacy, University of UtahOver the past few years, many innovative vaccines became available that offer protection for diseases which have never been prevented before. While there are several factors that could have an impact on access, the use of health technology assessment (HTA) undoubtedly is also one of the contributing factors. Objectives: To explore the landscape of vaccine access and the role of HTA in new vaccine adoption in Association of Southeast Asian Nations (ASEAN) countries. Results: A great deal of progress has been made in terms of access to new and innovation vaccine in the region. Variation in access to these vaccines comparing between countries, however, is still observed. The use of HTA in supporting new vaccine adoption is still in an early stage especially in Gavi, the Vaccine Alliance-eligible countries. Conclusions: Improving the use of HTA evidences to support decision making could accelerate the efficient adoption of new vaccine in ASEAN region.http://dx.doi.org/10.1080/21645515.2020.1769388vaccineaccesshealth technology assessmentaseannational immunization programexpanded program in immunization |
| spellingShingle | Suthira Taychakhoonavudh Woralak Chumchujan Raymond Hutubessy Nathorn Chaiyakunapruk Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries Human Vaccines & Immunotherapeutics vaccine access health technology assessment asean national immunization program expanded program in immunization |
| title | Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries |
| title_full | Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries |
| title_fullStr | Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries |
| title_full_unstemmed | Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries |
| title_short | Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries |
| title_sort | landscape of vaccine access and health technology assessment role in decision making process in asean countries |
| topic | vaccine access health technology assessment asean national immunization program expanded program in immunization |
| url | http://dx.doi.org/10.1080/21645515.2020.1769388 |
| work_keys_str_mv | AT suthirataychakhoonavudh landscapeofvaccineaccessandhealthtechnologyassessmentroleindecisionmakingprocessinaseancountries AT woralakchumchujan landscapeofvaccineaccessandhealthtechnologyassessmentroleindecisionmakingprocessinaseancountries AT raymondhutubessy landscapeofvaccineaccessandhealthtechnologyassessmentroleindecisionmakingprocessinaseancountries AT nathornchaiyakunapruk landscapeofvaccineaccessandhealthtechnologyassessmentroleindecisionmakingprocessinaseancountries |